Skip to main content
OpenTrials

Clinical trial condition

Female Urogenital Diseases and Pregnancy Complications

Explore clinical trials studying Female Urogenital Diseases and Pregnancy Complications. Study availability and eligibility vary by location and protocol.

27,094 public trials 4,558 recruiting studies
Refine in advanced search Browse all conditions

Female Urogenital Diseases and Pregnancy Complications trial results

Recruiting

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

NCT06580314

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +24 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 695 locations
View Trial Details
Recruiting

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

NCT04251052

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 574 locations
View Trial Details
Recruiting

Prospective Research Rare Kidney Stones (ProRKS)

NCT02780297

Conditions
Abnormalities, Multiple, Adenine Phosphoribosyltransferase Deficiency, Adenine phosphoribosyltransferase deficiency, +28 more
Locations
  • University of Alabama @ Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • Children's Memorial Hospital Chicago, Illinois, United States
  • Children's Hospital, Harvard Medical School Boston, Massachusetts, United States
View Trial Details
Recruiting

A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)

NCT04782258

Conditions
Abnormalities, Multiple, Autosomal Recessive Polycystic Kidney (ARPKD), Ciliopathies, +14 more
Locations
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Emory University Hospital Atlanta, Georgia, United States
  • Northwestern University Feinberg School of Medicine - Ann & Robert H. Lurie Children's Hospital of Chicago - Neonatology Chicago, Illinois, United States
  • Riley Hospital for Children Indianapolis, Indiana, United States
View all 23 locations
View Trial Details
Recruiting

A Study of DM002 in Patients With Advanced Solid Tumors

NCT06751329

Conditions
Adnexal Diseases, Colonic Diseases, Colorectal Neoplasms, +33 more
Locations
  • The University of Texas, MD Anderson Cancer Center Houston, Texas, United States
  • Scientia Clinical Research Randwick, New South Wales, Australia
  • Cancer Care Wollongong Wollongong, New South Wales, Australia
  • Southern Oncology Clinical Research Unit Adelaide, South Australia, Australia
View Trial Details
Recruiting

Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

NCT04291612

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +22 more
Locations
  • Hartford Healthcare Cancer Institute @ Hartford Hospital Hartford, Connecticut, United States
  • Miami Cancer Institute Baptist Health South Florida Miami, Florida, United States
  • ADVENTHEALTH (Data collection only) Orlando, Florida, United States
  • Mayo Clinic (Data Collection and Data Analysis) Rochester, Minnesota, United States
View all 18 locations
View Trial Details

Related conditions